210 related articles for article (PubMed ID: 9210466)
1. A conformational study of the human and rat encephalitogenic myelin oligodendrocyte glycoprotein peptides 35-55.
Albouz-Abo S; Wilson JC; Bernard CC; von Itzstein M
Eur J Biochem; 1997 May; 246(1):59-70. PubMed ID: 9210466
[TBL] [Abstract][Full Text] [Related]
2. Conformational analysis of a glycosylated human myelin oligodendrocyte glycoprotein peptide epitope able to detect antibody response in multiple sclerosis.
Carotenuto A; D'Ursi AM; Nardi E; Papini AM; Rovero P
J Med Chem; 2001 Jul; 44(14):2378-81. PubMed ID: 11428934
[TBL] [Abstract][Full Text] [Related]
3. Extracellular domain of myelin oligodendrocyte glycoprotein (MOG) exhibits solvent-dependent conformational transitions.
Ngu-Schwemlein M; Corzett M; Thornton KH; Balhorn R; Cosman M
Protein Pept Lett; 2003 Oct; 10(5):483-90. PubMed ID: 14561137
[TBL] [Abstract][Full Text] [Related]
4. Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides.
Ichikawa M; Johns TG; Adelmann M; Bernard CC
Int Immunol; 1996 Nov; 8(11):1667-74. PubMed ID: 8943561
[TBL] [Abstract][Full Text] [Related]
5. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice.
Mokhtarian F; Zhang Z; Shi Y; Gonzales E; Sobel RA
J Neuroimmunol; 1999 Mar; 95(1-2):43-54. PubMed ID: 10229114
[TBL] [Abstract][Full Text] [Related]
6. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
[TBL] [Abstract][Full Text] [Related]
7. Demyelinating myelin oligodendrocyte glycoprotein-specific autoantibody response is focused on one dominant conformational epitope region in rodents.
Breithaupt C; Schäfer B; Pellkofer H; Huber R; Linington C; Jacob U
J Immunol; 2008 Jul; 181(2):1255-63. PubMed ID: 18606679
[TBL] [Abstract][Full Text] [Related]
8. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
Kerlero de Rosbo N; Mendel I; Ben-Nun A
Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
[TBL] [Abstract][Full Text] [Related]
9. Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls.
Van der Aa A; Hellings N; Bernard CC; Raus J; Stinissen P
J Neuroimmunol; 2003 Apr; 137(1-2):164-76. PubMed ID: 12667661
[TBL] [Abstract][Full Text] [Related]
10. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice.
Mendel Kerlero de Rosbo N; Ben-Nun A
Eur J Immunol; 1996 Oct; 26(10):2470-9. PubMed ID: 8898962
[TBL] [Abstract][Full Text] [Related]
11. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Weissert R; de Graaf KL; Storch MK; Barth S; Linington C; Lassmann H; Olsson T
J Immunol; 2001 Jun; 166(12):7588-99. PubMed ID: 11390515
[TBL] [Abstract][Full Text] [Related]
12. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells.
Mendel I; Kerlero de Rosbo N; Ben-Nun A
Eur J Immunol; 1995 Jul; 25(7):1951-9. PubMed ID: 7621871
[TBL] [Abstract][Full Text] [Related]
13. Folding of peptide fragments comprising the complete sequence of proteins. Models for initiation of protein folding. I. Myohemerythrin.
Dyson HJ; Merutka G; Waltho JP; Lerner RA; Wright PE
J Mol Biol; 1992 Aug; 226(3):795-817. PubMed ID: 1507227
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55.
Ichikawa M; Johns TG; Liu J; Bernard CC
J Immunol; 1996 Jul; 157(2):919-26. PubMed ID: 8752946
[TBL] [Abstract][Full Text] [Related]
15. Cloning and cDNA sequence analysis of myelin/oligodendrocyte glycoprotein: a novel member of the immunoglobulin gene superfamily.
Gardinier MV; Matthieu JM
Schweiz Arch Neurol Psychiatr (1985); 1993; 144(3):201-7. PubMed ID: 7687365
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology.
Marta CB; Oliver AR; Sweet RA; Pfeiffer SE; Ruddle NH
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13992-7. PubMed ID: 16172404
[TBL] [Abstract][Full Text] [Related]
17. Encephalitogenic epitopes of myelin basic protein, proteolipid protein, myelin oligodendrocyte glycoprotein for experimental allergic encephalomyelitis induction in Biozzi ABH (H-2Ag7) mice share an amino acid motif.
Amor S; O'Neill JK; Morris MM; Smith RM; Wraith DC; Groome N; Travers PJ; Baker D
J Immunol; 1996 Apr; 156(8):3000-8. PubMed ID: 8609422
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein.
Breithaupt C; Schubart A; Zander H; Skerra A; Huber R; Linington C; Jacob U
Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9446-51. PubMed ID: 12874380
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of chicken and human parathyroid hormone-(1-34)-peptides in solution with SDS.
Kanaori K; Takai M; Nosaka AY
Eur J Biochem; 1997 Nov; 249(3):878-85. PubMed ID: 9395339
[TBL] [Abstract][Full Text] [Related]
20. The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis.
Clements CS; Reid HH; Beddoe T; Tynan FE; Perugini MA; Johns TG; Bernard CC; Rossjohn J
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):11059-64. PubMed ID: 12960396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
